30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Sethuraman Natarajan

Insider profile

Sethuraman Natarajan's trades of Entrada Therapeutics Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-04 2026-05-04 PlS Planned sale
81,529 -17.1%
229.92
US$755,304
81,529 -17.1% 229.92 US$755,304
2026-05-04 2026-05-04 PrS Proposed sale
23,137
227.70
US$4,976,893
23,137 227.70 US$4,976,893
2024-12-03 2024-12-03 PlS Planned sale
67,311 +22.5%
201.91
US$2,250,717
67,311 +22.5% 201.91 US$2,250,717
2024-12-03 2024-12-02 PlS Planned sale
4,088 -2.5%
20.26
US$82,834
4,088 -2.5% 20.26 US$82,834
2024-12-03 2024-11-29 PlS Planned sale
100 -0.1%
20.00
US$2,000
100 -0.1% 20.00 US$2,000
2024-11-13 2024-11-13 PlS Planned sale
2,700 -1.7%
20.04
US$54,109
2,700 -1.7% 20.04 US$54,109
2024-11-13 2024-11-11 PlS Planned sale
1,409 -0.9%
20.01
US$28,191
1,409 -0.9% 20.01 US$28,191
2024-11-12 2024-11-11 PrS Proposed sale
18,762
19.82
US$371,863
18,762 19.82 US$371,863
2024-11-06 2024-11-06 PlS Planned sale
2,745 -1.6%
19.32
US$53,024
2,745 -1.6% 19.32 US$53,024
2024-11-06 2024-11-06 PlS Planned sale
9,554 -5.4%
18.71
US$178,752
9,554 -5.4% 18.71 US$178,752
2024-11-06 2024-11-05 PlS Planned sale
5,171 -2.8%
18.18
US$94,006
5,171 -2.8% 18.18 US$94,006
2024-11-06 2024-11-04 PlS Planned sale
749 -0.4%
18.02
US$13,498
749 -0.4% 18.02 US$13,498
2024-10-18 2024-10-16 PlS Planned sale
600 -0.3%
18.00
US$10,800
600 -0.3% 18.00 US$10,800
2024-10-16 2024-10-16 PrS Proposed sale
20,057
17.53
US$351,599
20,057 17.53 US$351,599
2024-09-10 2024-09-09 PlS Planned sale
2,642 -1.4%
15.09
US$39,862
2,642 -1.4% 15.09 US$39,862
2024-09-10 2024-09-06 PlS Planned sale
600 -0.3%
15.24
US$9,141
600 -0.3% 15.24 US$9,141
2024-07-16 2024-07-15 PlS Planned sale
638 -0.3%
18.00
US$11,484
638 -0.3% 18.00 US$11,484
2024-07-16 2024-07-12 PlS Planned sale
600 -0.3%
18.00
US$10,800
600 -0.3% 18.00 US$10,800
2024-07-12 2024-07-12 PrS Proposed sale
20,057
17.37
US$348,390
20,057 17.37 US$348,390
2024-05-20 2024-05-20 PlS Planned sale
9,675 -4.8%
15.19
US$146,944
9,675 -4.8% 15.19 US$146,944
2024-05-20 2024-05-20 PlS Planned sale
9,675 -4.8%
15.19
US$146,944
9,675 -4.8% 15.19 US$146,944
2024-05-20 2024-05-17 PlS Planned sale
8,305 -4.0%
15.14
US$125,751
8,305 -4.0% 15.14 US$125,751
2024-05-20 2024-05-17 PlS Planned sale
8,305 -4.0%
15.14
US$125,751
8,305 -4.0% 15.14 US$125,751
2024-05-20 2024-05-16 PlS Planned sale
1,000 -0.5%
15.00
US$15,000
1,000 -0.5% 15.00 US$15,000
2024-05-20 2024-05-16 PlS Planned sale
1,000 -0.5%
15.00
US$15,000
1,000 -0.5% 15.00 US$15,000
2024-05-16 2024-05-16 PrS Proposed sale
18,980
14.49
US$275,020
18,980 14.49 US$275,020
2023-07-12 2023-07-11 PlS Planned sale
14,852 -8.8%
18.04
US$267,915
14,852 -8.8% 18.04 US$267,915
2023-07-12 2023-07-10 PlS Planned sale
3,026 -1.8%
18.00
US$54,474
3,026 -1.8% 18.00 US$54,474
2023-04-19 2023-04-17 PlS Planned sale
3,961 -2.3%
18.00
US$71,316
3,961 -2.3% 18.00 US$71,316
2023-04-17 2023-04-17 PrS Proposed sale
21,839
17.25
US$376,723
21,839 17.25 US$376,723